Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Xetra  >  Siemens    SIE   DE0007236101

SIEMENS (SIE)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles

Siemens AG : WSJ BLOG/Health : Siemens Sees Resurgence in Diagnostics as a Cost Cutter

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/13/2012 | 07:02pm CEST

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Shirley S. Wang

The Health Blog caught up at TEDMED with Gregory Sorensen, chief executive of Siemens Healthcare in North America, to talk about the changing health-care field and what it means for diagnostics, an area in which Siemens is a player.

"We're beginning to see resurgence in diagnostics as a way to save costs, " Sorensen, formerly a radiology professor at Harvard Medical School, told the Health Blog.

A missed diagnosis is a big cost driver in health care because it wastes time and money on ineffective therapy, he said, pointing to an example of studies in Alzheimer's showing that upon autopsy, some 15%-20% of patients examined had a different ailment than believed and would have been treated differently when they were alive.

Of course, there's been an outcry about the unnecessary use of medical tests and Sorensen acknowledges there has been overuse in the past. Reductions in Medicare reimbursement rates have curbed overuse, he says, though not everyone agrees on that, as the Health Blog reported last week. The important thing now, Sorensen says, is to make sure people are getting the right diagnostic tests, rather than reduce the absolute number of them.

He recalled being a doctor in training in the late 1980s, when his professors taught him that, because of the risks associated with appendicitis, doctors should be conservative whenever a patient reported pain in the lower right quadrant of the abdomen. A good surgeon, therefore, would do exploratory surgery on five patients for every one that actually had appendicitis. Sorensen himself had his appendix -- which turned out to be healthy -- removed during this era.

Now patients get scanned if they report such pain, resulting in many fewer unnecessary surgeries, said Sorensen.

Siemens recognizes how important it is to demonstrate effectiveness in today's health-care business, and that payers want to see results, says Sorensen. As for the shift to reimbursement for value, "that train has left the station."

 
 -For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com. 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SIEMENS
05:38pSIEMENS : UK boss - Give us clarity on how post-Brexit trade will work
RE
06/19SIEMENS : CEO dismisses report of large turbines unit sell-off
RE
06/19SIEMENS : Voith and Siemens sign cooperation agreement to offer a condition moni..
AQ
06/19SIEMENS : and Lempaalan Energia to Build Microgrid in Finland
DJ
06/19OIL AND GAS SECURITY AND SERVICE MAR : Global Oil and Gas Security and Service M..
AQ
06/18ALSTOM : EU regulators to include Chinese rival in review of Siemens, Alstom dea..
RE
06/18SIEMENS AKTIENGESELLSCHAFT : Release of a capital market information
EQ
06/18SIEMENS' : Teamcenter on Amazon Web Services enhances cost-effective cloud deplo..
AQ
06/17Siemens wins £1.5 billion contract to build new London Tube trains
RE
06/16Siemens wins $2 billion contract to build new London Tube trains
RE
More news
News from SeekingAlpha
06/19Schneider Has Put The Pieces In Place To Drive Higher-Value Growth 
06/18Siemens wins £1.5B contract to build new London Tube trains 
06/15Siemens (SIEGY) Presents At J.P. Morgan Cazenove European Capital Goods CEO C.. 
06/13Siemens mulls turbine business sale 
06/12Siemens (SIEGY) Presents At Exane BNP Paribas European CEO Conference - Slide.. 
Financials (€)
Sales 2018 83 533 M
EBIT 2018 7 426 M
Net income 2018 6 016 M
Debt 2018 17 056 M
Yield 2018 3,29%
P/E ratio 2018 16,05
P/E ratio 2019 15,35
EV / Sales 2018 1,41x
EV / Sales 2019 1,33x
Capitalization 101 B
Chart SIEMENS
Duration : Period :
Siemens Technical Analysis Chart | SIE | DE0007236101 | 4-Traders
Technical analysis trends SIEMENS
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 27
Average target price 132 €
Spread / Average Target 13%
EPS Revisions
Managers
NameTitle
Josef Kaeser President & Chief Executive Officer
Jim Hagemann Snabe Chairman-Supervisory Board
Ralf Peter Thomas Chief Financial Officer
Roland Emil Busch Chief Technology Officer
Helmuth Ludwig Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
SIEMENS2.99%116 493
3M COMPANY-13.26%121 214
GENERAL ELECTRIC COMPANY-23.78%114 646
HONEYWELL INTERNATIONAL-2.04%112 002
ILLINOIS TOOL WORKS-10.91%49 364
JARDINE MATHESON HOLDINGS LIMITED1.56%46 021